Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Pathology
|
March 18, 2025
Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of Australasia
Wendy A Cooper, Benhur Amanuel, Caroline Cooper, et al.
Frontiers in Oncology
|
December 25, 2025
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors
David Gill, Charles L Cowey, Gregory A Daniels, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 20, 2024
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation
David M Waterhouse, Sacha Rothschild, Christophe Dooms, et al.
Pigment Cell & Melanoma Research
|
February 16, 2019
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies
Ines Pires da Silva, Isabella C Glitza, Lauren E Haydu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience
Francis Proulx-Rocray, Rebecca Symons, Yang Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2024
Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy
Rachel Woodford, Janet McKeown, Lotte L Hoeijmakers, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Prachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Pathology
|
March 18, 2025
Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of Australasia
Wendy A Cooper, Benhur Amanuel, Caroline Cooper, et al.
Frontiers in Oncology
|
December 25, 2025
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors
David Gill, Charles L Cowey, Gregory A Daniels, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 20, 2024
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation
David M Waterhouse, Sacha Rothschild, Christophe Dooms, et al.
Pigment Cell & Melanoma Research
|
February 16, 2019
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies
Ines Pires da Silva, Isabella C Glitza, Lauren E Haydu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience
Francis Proulx-Rocray, Rebecca Symons, Yang Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2024
Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy
Rachel Woodford, Janet McKeown, Lotte L Hoeijmakers, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Prachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.
Page
of 2